Bioventix (LON:BVXP) Sets New 52-Week Low – What’s Next?

Bioventix PLC (LON:BVXP) shares hit a new 52-week low during mid-day trading on Monday . The company traded as low as GBX 1,600 and last traded at GBX 1,628, with a volume of 11238 shares changing hands. The stock had previously closed at GBX 1,699.

Bioventix Price Performance

The company has a fifty day moving average price of GBX 1,786.43 and a 200 day moving average price of GBX 2,097.06. The company has a market cap of £85.06 million, a PE ratio of 11.36 and a beta of 0.35.

Insider Buying and Selling

In related news, insider Bruce Hiscock purchased 150 shares of the business’s stock in a transaction on Tuesday, November 25th. The stock was acquired at an average price of GBX 2,071 per share, with a total value of £3,106.50. 6.16% of the stock is currently owned by corporate insiders.

Bioventix Company Profile

Bioventix PLC creates, manufactures, and supplies sheep monoclonal antibodies (SMAs) for diagnostic applications worldwide. The company offers a portfolio of purified SMAs for thyroid, vitamin D, cardiac, drugs of abuse, fertility, oncology, and miscellaneous indications; and Pyrene (HOP-G) ELISA kit to monitor human exposure to industrial pollutants. It also provides contract SMAs and recombinant services. Bioventix PLC was incorporated in 2003 and is based in Farnham, United Kingdom.